Vanessa Azevedo Voltarelli, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Physical Conditioning, Animal | 10 | 2021 | 363 | 1.580 |
Why?
|
Receptors, Adrenergic, beta-2 | 4 | 2021 | 216 | 1.210 |
Why?
|
Glycogen Storage Disease Type V | 1 | 2023 | 8 | 0.860 |
Why?
|
Muscle, Skeletal | 11 | 2021 | 4968 | 0.750 |
Why?
|
Muscular Atrophy | 6 | 2021 | 335 | 0.700 |
Why?
|
Physical Endurance | 1 | 2012 | 369 | 0.340 |
Why?
|
Cachexia | 3 | 2021 | 202 | 0.240 |
Why?
|
Carbon Monoxide | 2 | 2024 | 560 | 0.220 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2023 | 106 | 0.220 |
Why?
|
Platelet Factor 4 | 1 | 2023 | 131 | 0.220 |
Why?
|
Acclimatization | 1 | 2023 | 113 | 0.200 |
Why?
|
Hyperbaric Oxygenation | 1 | 2023 | 167 | 0.190 |
Why?
|
Hydrogen Sulfide | 1 | 2022 | 148 | 0.180 |
Why?
|
Heart Failure | 5 | 2017 | 11879 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 678 | 0.170 |
Why?
|
Exercise | 3 | 2023 | 5945 | 0.170 |
Why?
|
Colonic Neoplasms | 2 | 2023 | 2535 | 0.170 |
Why?
|
Neoplasms | 4 | 2023 | 22350 | 0.160 |
Why?
|
Oxidative Stress | 2 | 2021 | 3139 | 0.160 |
Why?
|
Oxidation-Reduction | 5 | 2021 | 2221 | 0.160 |
Why?
|
Muscle Fibers, Slow-Twitch | 2 | 2021 | 52 | 0.150 |
Why?
|
Muscle Fibers, Fast-Twitch | 2 | 2021 | 70 | 0.150 |
Why?
|
Mitochondria | 1 | 2021 | 3678 | 0.140 |
Why?
|
Doxorubicin | 1 | 2024 | 2229 | 0.140 |
Why?
|
Muscle Fatigue | 1 | 2017 | 96 | 0.140 |
Why?
|
Myocytes, Cardiac | 2 | 2018 | 1672 | 0.140 |
Why?
|
Rats, Wistar | 5 | 2021 | 1887 | 0.130 |
Why?
|
Acetylcysteine | 1 | 2017 | 262 | 0.130 |
Why?
|
Exercise Therapy | 2 | 2021 | 935 | 0.130 |
Why?
|
Muscle Contraction | 2 | 2018 | 1208 | 0.130 |
Why?
|
Adaptation, Physiological | 1 | 2023 | 1312 | 0.130 |
Why?
|
Neuromuscular Diseases | 1 | 2018 | 260 | 0.130 |
Why?
|
Myocardial Infarction | 3 | 2017 | 11514 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2024 | 7869 | 0.120 |
Why?
|
Rats | 6 | 2021 | 23717 | 0.120 |
Why?
|
Signal Transduction | 4 | 2021 | 23618 | 0.110 |
Why?
|
Animals | 18 | 2024 | 168939 | 0.110 |
Why?
|
Myocardial Contraction | 1 | 2018 | 1516 | 0.110 |
Why?
|
Citrate (si)-Synthase | 1 | 2012 | 48 | 0.100 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1281 | 0.100 |
Why?
|
Autophagy | 2 | 2018 | 1345 | 0.100 |
Why?
|
Mitochondrial Proteins | 1 | 2018 | 980 | 0.100 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 61 | 0.100 |
Why?
|
Adenylate Kinase | 1 | 2012 | 101 | 0.100 |
Why?
|
Glycogen | 1 | 2012 | 252 | 0.100 |
Why?
|
Succinate Dehydrogenase | 1 | 2012 | 148 | 0.100 |
Why?
|
Muscular Diseases | 1 | 2016 | 551 | 0.090 |
Why?
|
Heart Diseases | 2 | 2024 | 2817 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1492 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2017 | 1319 | 0.090 |
Why?
|
Cell Respiration | 1 | 2021 | 201 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2018 | 14473 | 0.090 |
Why?
|
Mice | 9 | 2024 | 81898 | 0.080 |
Why?
|
Sympathetic Nervous System | 1 | 2012 | 520 | 0.080 |
Why?
|
Proteins | 2 | 2016 | 6002 | 0.080 |
Why?
|
Antioxidants | 1 | 2017 | 1671 | 0.080 |
Why?
|
Up-Regulation | 1 | 2018 | 4143 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2979 | 0.080 |
Why?
|
Ubiquitin | 1 | 2014 | 841 | 0.080 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2021 | 482 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2012 | 845 | 0.070 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2020 | 553 | 0.060 |
Why?
|
Carboxyhemoglobin | 1 | 2024 | 83 | 0.060 |
Why?
|
Heart | 2 | 2017 | 4425 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3702 | 0.050 |
Why?
|
Myocardium | 1 | 2016 | 4765 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2023 | 6225 | 0.050 |
Why?
|
Splenomegaly | 1 | 2023 | 191 | 0.050 |
Why?
|
Heme Oxygenase-1 | 1 | 2024 | 364 | 0.050 |
Why?
|
Gases | 1 | 2022 | 205 | 0.050 |
Why?
|
Echocardiography | 1 | 2014 | 5038 | 0.050 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2020 | 58 | 0.040 |
Why?
|
Male | 11 | 2021 | 364154 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 501 | 0.040 |
Why?
|
Myoblasts | 1 | 2020 | 234 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1250 | 0.040 |
Why?
|
Glycolysis | 1 | 2021 | 837 | 0.030 |
Why?
|
Muscle Proteins | 2 | 2012 | 1160 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18329 | 0.030 |
Why?
|
Chloroquine | 1 | 2018 | 276 | 0.030 |
Why?
|
Cell Line | 1 | 2021 | 15564 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4019 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1604 | 0.030 |
Why?
|
Heart Function Tests | 1 | 2016 | 315 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 17089 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22351 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2023 | 1594 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16722 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21162 | 0.030 |
Why?
|
Humans | 7 | 2024 | 766812 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2023 | 2057 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 694 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2140 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6105 | 0.030 |
Why?
|
Mice, Inbred mdx | 1 | 2012 | 90 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 869 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3605 | 0.020 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2012 | 174 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 88902 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3934 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4252 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2012 | 685 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2018 | 18986 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3926 | 0.020 |
Why?
|
Norepinephrine | 1 | 2012 | 898 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3942 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2020 | 2903 | 0.020 |
Why?
|
Exercise Test | 1 | 2017 | 2188 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12795 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2018 | 1383 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3587 | 0.020 |
Why?
|
NF-kappa B | 1 | 2017 | 2493 | 0.020 |
Why?
|
Atrophy | 1 | 2012 | 1631 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8108 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3915 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2144 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9546 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8310 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4349 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2012 | 1627 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7438 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10384 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13642 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9407 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2012 | 1900 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2012 | 3317 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13476 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9464 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5783 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27158 | 0.010 |
Why?
|
Female | 2 | 2024 | 396532 | 0.010 |
Why?
|